Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
3.310
-0.020 (-0.60%)
Oct 23, 2025, 9:53 AM EDT - Market open
Camp4 Therapeutics Revenue
Camp4 Therapeutics had revenue of $1.50M in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $3.01M, up 759.14% year-over-year. In the year 2024, Camp4 Therapeutics had annual revenue of $652.00K with 86.29% growth.
Revenue (ttm)
$3.01M
Revenue Growth
+759.14%
P/S Ratio
16.09
Revenue / Employee
$54,673
Employees
55
Market Cap
155.05M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 652.00K | 302.00K | 86.29% |
Dec 31, 2023 | 350.00K | - | - |
Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCAMP News
- 22 days ago - CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01 - GlobeNewsWire
- 6 weeks ago - CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders - GlobeNewsWire
- 2 months ago - CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 5 months ago - CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting - GlobeNewsWire
- 5 months ago - CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 6 months ago - CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting - GlobeNewsWire
- 7 months ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2 - Benzinga
- 7 months ago - CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire